Cargando…
The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
Glucocorticosteroids are the mainstay of treatment of active Crohn's disease and ulcerative colitis. These drugs however carry important cosmetic short-term side effects and when used long-term they induce severe irreversible complications. Topically acting glucocorticosteroids, especially bude...
Autor principal: | Rutgeerts, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781841/ https://www.ncbi.nlm.nih.gov/pubmed/9705597 |
Ejemplares similares
-
Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2022) -
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
por: Dubois-Camacho, Karen, et al.
Publicado: (2017) -
Glucocorticosteroid in Treatment of Severe Pneumonia
por: Ariani, Felinda, et al.
Publicado: (2013) -
THE RETROSPECTIVE ANALYSIS OF GLUCOCORTICOSTEROIDS USE IN THE TREATMENT OF SARS IN BEIJING
por: Wang, Guangfa, et al.
Publicado: (2007) -
Vaccination and infection prevention in inflammatory bowel disease
por: Vermeire, Severine, et al.
Publicado: (2010)